halothane has been researched along with indomethacin in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (38.89) | 18.7374 |
| 1990's | 8 (44.44) | 18.2507 |
| 2000's | 2 (11.11) | 29.6817 |
| 2010's | 1 (5.56) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dansette, PM; Fontana, E; Poli, SM | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Baek, WY; Hatano, Y; Mori, K; Nakamura, K; Nishiwada, M; Toda, H | 1 |
| Hurst, T; Johnson, D; Mayers, I | 1 |
| Johns, RA; Stone, DJ | 1 |
| Lauritzen, M | 1 |
| Fletcher, JE; Rosenberg, H | 2 |
| Adkinson, NF; Gurtner, GH; Sciuto, AM; Shayevitz, JR; Traystman, RJ | 1 |
| Kataja, J; Kaukinen, S; Ylitalo, P | 1 |
| Harrison, MR; Nakayama, DK; Seron-Ferre, M; Villa, RL | 1 |
| Jones, KA; Lorenz, RR; Morimoto, N; Sieck, GC; Warner, DO | 1 |
| Bosnjak, ZJ; Hogan, QH; Kampine, JP; Stadnicka, A; Stekiel, TA | 1 |
| Hatano, Y; Kakuyama, M; Mori, K; Nakamura, K; Nishiwada, M; Terasako, K; Toda, H | 1 |
| Aubier, M; Boczkowski, J; de Larminat, V; Desmonts, JM; Dureuil, B; Farinotti, R; Vicaut, E | 1 |
| Dai, HB; Darvish, A; Lowenstein, E; Park, KW; Sellke, FW | 1 |
| Horibe, M; Murray, PA; Seki, S | 1 |
1 review(s) available for halothane and indomethacin
| Article | Year |
|---|---|
Cytochrome p450 enzymes mechanism based inhibitors: common sub-structures and reactivity.
Topics: Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Interactions; Enzyme Inhibitors; Humans; Isoenzymes; Structure-Activity Relationship; Terminology as Topic | 2005 |
17 other study(ies) available for halothane and indomethacin
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Halothane-induced relaxation of vascular smooth muscle: a possible contribution of increased cyclic GMP formation.
Topics: Animals; Cyclic GMP; Dexamethasone; Halothane; In Vitro Techniques; Indomethacin; Male; Methylene Blue; Muscle, Smooth, Vascular; Rats; Rats, Inbred Strains; Vasodilator Agents | 1991 |
Halothane inhibits hypoxic pulmonary vasoconstriction in the presence of cyclooxygenase blockade.
Topics: Animals; Cyclooxygenase Inhibitors; Dogs; Halothane; Hypoxia; In Vitro Techniques; Indomethacin; Lung; Vasoconstriction | 1990 |
Endothelium-dependent effects of halothane, enflurane, and isoflurane on isolated rat aortic vascular rings.
Topics: Animals; Aorta, Thoracic; Drug Interactions; Endothelium, Vascular; Enflurane; Halothane; In Vitro Techniques; Indomethacin; Isoflurane; Male; Rats; Rats, Inbred Strains; Vasoconstriction; Vasodilation | 1989 |
Regional cerebral blood flow during cortical spreading depression in rat brain: increased reactive hyperperfusion in low-flow states.
Topics: Anesthesia, General; Animals; Carbon Dioxide; Cerebral Cortex; Cortical Spreading Depression; Halothane; Indomethacin; Male; Oxygen; Rats; Rats, Inbred Strains; Regional Blood Flow; Vasoconstriction; Vasodilation | 1987 |
In vitro muscle contractures induced by halothane and suxamethonium. I: The rat diaphragm.
Topics: Animals; Dantrolene; Diaphragm; Drug Synergism; Halothane; In Vitro Techniques; Indomethacin; Male; Muscle Contraction; Quinacrine; Rats; Rats, Inbred Strains; Spermine; Succinylcholine; Tubocurarine | 1986 |
In vitro muscle contractures induced by halothane and suxamethonium. II: Human skeletal muscle from normal and malignant hyperthermia susceptible patients.
Topics: Disease Susceptibility; Fatty Acids, Nonesterified; Halothane; Humans; In Vitro Techniques; Indomethacin; Malignant Hyperthermia; Muscle Contraction; Muscles; Phospholipases A; Phospholipases A2; Quinacrine; Spermine; Succinylcholine | 1986 |
Inhalation anesthetics augment oxidant-induced pulmonary vasoconstriction: evidence for a membrane effect.
Topics: 6-Ketoprostaglandin F1 alpha; Analysis of Variance; Anesthesia, Inhalation; Anesthetics; Animals; Arachidonic Acids; Blood Pressure; Cell Membrane; Cyclooxygenase Inhibitors; Halothane; In Vitro Techniques; Indomethacin; Male; Peroxides; Pulmonary Artery; Pulmonary Circulation; Rabbits; tert-Butylhydroperoxide; Thromboxane B2; Vasoconstriction | 1985 |
Circulatory effects of renin-angiotensin system antagonists during halothane anaesthesia in hypertensive rats.
Topics: Angiotensin II; Animals; Antihypertensive Agents; Blood Pressure; Captopril; Enflurane; Halothane; Heart Rate; Hypertension; Indomethacin; Male; Proline; Rats; Renin-Angiotensin System; Saralasin; Shock, Hemorrhagic | 1983 |
Fetal surgery in the primate II. Uterine electromyographic response to operative procedures and pharmacologic agents.
Topics: Amniocentesis; Anesthesia, Obstetrical; Animals; Catheterization; Electrodes, Implanted; Electromyography; Female; Fetus; Halothane; Indomethacin; Macaca mulatta; Monitoring, Physiologic; Obstetric Labor, Premature; Pregnancy; Ritodrine; Uterus | 1984 |
Halothane reduces force and intracellular Ca2+ in airway smooth muscle independently of cyclic nucleotides.
Topics: 1-Methyl-3-isobutylxanthine; Animals; Calcium; Cyclic AMP; Dogs; Female; Halothane; Indomethacin; Intracellular Membranes; Isometric Contraction; Isoproterenol; Male; Muscle, Smooth; Nucleotides, Cyclic; Trachea | 1995 |
Hypoxic contraction of isolated rabbit mesenteric veins. Contribution of endothelium and attenuation by volatile anesthetics.
Topics: Acetylcholine; Animals; Arginine; Endothelium, Vascular; Enflurane; Glycopeptides; Halothane; Hypoxia; In Vitro Techniques; Indomethacin; Isoflurane; Male; Masoprocol; NG-Nitroarginine Methyl Ester; Nicardipine; Norepinephrine; Peptides, Cyclic; Rabbits; Ryanodine; Vasoconstriction | 1995 |
Halothane and enflurane constrict canine mesenteric arteries by releasing Ca2+ from intracellular Ca2+ stores.
Topics: Animals; Arginine; Caffeine; Calcium; Dogs; Enflurane; Fluorescent Dyes; Fura-2; Halothane; In Vitro Techniques; Indomethacin; Isometric Contraction; Mesenteric Arteries; Muscle, Smooth, Vascular; Nifedipine; Nitroarginine; Ryanodine; Spectrometry, Fluorescence; Vasoconstriction | 1994 |
Role of prostaglandins and nitric oxide on halothane-induced arteriolar dilatation in rat diaphragm.
Topics: Anesthetics, Inhalation; Animals; Arterioles; Diaphragm; Halothane; Indomethacin; Male; Mefenamic Acid; Nitric Oxide; Nitric Oxide Synthase; Nitroarginine; Prostaglandins; Rats; Rats, Sprague-Dawley; Vasodilation | 1996 |
Isoflurane and halothane attenuate endothelium-dependent vasodilation in rat coronary microvessels.
Topics: 8-Bromo Cyclic Adenosine Monophosphate; Acetylcholine; Anesthetics, Inhalation; Animals; Calcimycin; Calcium; Coronary Circulation; Endothelium, Vascular; Enzyme Inhibitors; Epoprostenol; Halothane; In Vitro Techniques; Indomethacin; Ionophores; Isoflurane; Microcirculation; Microscopy, Video; Nitric Oxide; Nitric Oxide Synthase; Nitroarginine; Nitroprusside; Rats; Rats, Wistar; Vasoconstriction; Vasodilation; Vasodilator Agents | 1997 |
Halothane attenuates endothelium-dependent pulmonary vasorelaxant response to lemakalim, an adenosine triphosphate (ATP)-sensitive potassium channel agonist.
Topics: Adenosine Triphosphate; Anesthetics, Inhalation; Animals; Benzopyrans; Cromakalim; Dogs; Endothelium, Vascular; Glyburide; Halothane; Humans; Indomethacin; Muscle, Smooth, Vascular; NG-Nitroarginine Methyl Ester; Potassium Channels; Pulmonary Artery; Pyrroles; Vasodilation; Vasodilator Agents | 1997 |